Drug
Sodium Oxybate
Sodium Oxybate: highest development phase Phase 2/3, developed by Jazz Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Jazz Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sodium Oxybate NCT00514995 | Phase 2/3 | Binge Eating Disorder |
| sodium oxybate NCT00641186 | Phase 2 | Parkinson Disease |
Latest
No recent events.
Follow Sodium Oxybate on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.